Search Results - Krie, A.K

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Improved quality of life for early stage estrogen positive cancer survivors on a low-carbohydrate, calorie-restricted dietary intervention

    Improved quality of life for early stage estrogen positive cancer survivors on a low-carbohydrate, calorie-restricted dietary intervention by Krie, A.K, Demuth, H, Bohlen, K.N, Hu, Y, Fagerness, M.S, Flier, N.L, Kittelsrud, J, Weber, Z.M, Ehli, E.A

    Published in Gynecologic oncology
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    A low-carbohydrate nutritional program improves weight, insulin, and estrogenic parameters in obese patients with estrogen receptor positive endometrial cancer

    A low-carbohydrate nutritional program improves weight, insulin, and estrogenic parameters in obese patients with estrogen receptor positive endometrial cancer by Krie, A.K, Weber, Z.M, Bohlen, K.N, Hu, Y, Fagerness, M.S, Flier, N.L, Kittelsrud, J, Davies, G.E, Ehli, E.A

    Published in Gynecologic oncology
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    A low-carbohydrate nutritional program improves adiposity, metabolic, and nutritional parameters in obese patients with estrogen receptor positive endometrial and breast cancer

    A low-carbohydrate nutritional program improves adiposity, metabolic, and nutritional parameters in obese patients with estrogen receptor positive endometrial and breast cancer by Krie, A.K, Weber, Z.M, Bohlen, K.N, Hu, Y, Fagerness, M.S, Kittelsrud, J, Flier, N.L, Davies, G.E, Ehli, E.A

    Published in Gynecologic oncology
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Early results of a phase I evaluation of TAK-228 (TORC 1/2 inhibitor) in combination with TAK-117 (PI3K alpha inhibitor) and paclitaxel in advanced gynecologic malignancies and metastatic breast cancer

    Early results of a phase I evaluation of TAK-228 (TORC 1/2 inhibitor) in combination with TAK-117 (PI3K alpha inhibitor) and paclitaxel in advanced gynecologic malignancies and met... by Williams, C.B., Williams, K.A., Krie, A.K., Flier, N.L., Schwingler, S., Coppock, R., Lockhorst, R., Middendorff, G., Leyland-Jones, B., Dey, N., De, P., Rojas-Espaillat, L.A., Starks, D.C.

    Published in Gynecologic oncology
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: